Daily Business Update from the Boston Globe

To ensure you receive your Boston.com e-mails, please add newsletters@boston.com to your address book. If you have trouble reading this e-mail, go to http://www.boston.com/business/ticker_headlines
Get up-to-the-minute Globe Business Updates   |  More Business News
	ADVERTISEMENT Monday, January 24, 2011 Beacon Power begins commercial operations in NY Beacon Power Corp., an energy storage company based in Tyngsborough, said that it has energized and interconnected eight megawatts of flywheel energy storage and is now earning revenue at its frequency regulation plant in Stephentown, N.Y. Ad agency Mullen lands new client EmblemHealth, a New York-based health-care company, has selected Mullen to be its new brand advertising agency of record after a competitive agency review process, Boston-based Mullen said today. Buy groceries at Cumberland Farms drive-thru store Getting a cup of coffee at the drive-through window is no big deal, but now at a new Cumberland Farms store in Kingston, drive-through customers can buy bread, eggs, and cereal as well without getting out of their cars. Local gas prices rise another penny a gallon The average price for gas in Massachusetts is $3.109 a gallon in the latest weekly survey from AAA, up 1 cent from the previous week's average, AAA Southern New England said today. Nuclea partners with Boston Medical Center Nuclea Biotechnologies Inc., a Pittsfield company focused on biomarkers, announced a new partnership with Boston Medical Center that has the potential to lead to more effective treatments for people with breast and prostate cancers. Raytheon gets $145m contract for Kuwait defense Raytheon Co. will make Patriot missiles for Kuwait's air and missile defense systems under a new $145 million contract, the Waltham-based defense contractor said today. PerkinElmer launches next-generation DNA services PerkinElmer Inc., a Waltham life sciences company, said today that it has launched the launch of its next generation DNA sequencing and data analysis services, which can enable researchers to better explore the genomic origins of disease. Clinical Data gets FDA OK for depression drug Biotechnology company Clinical Data Inc. said this morning that the Food and Drug Administration approved the major depressive disorder treatment Viibryd. Clinical Data shares surged more than 40 percent in pre-market trading. Cabot Clothbound Cheddar claims a prize Cabot Clothbound Cheddar, a leading example of Vermont's artisanal cheese making industry, wins a prize at a food awards ceremony. Sanofi extends Genzyme tender offer French drugmaker Sanofi-Aventis SA has extended its tender offer for Cambridge-based biotechnology company Genzyme Corp., giving the parties more time to conclude a acquisition deal.